Similar articles

• [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].

  Salvesen C, Vaksdal K. Salvesen C, et al. Tidsskr Nor Laegeforen. 1973 Aug 30;93(24):1699-703. Tidsskr Nor Laegeforen. 1973. PMID: 4149082 Norwegian. No abstract available.
• Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.

  Salvesen C, Vaksdal K. Salvesen C, et al. Behav Neuropsychiatry. 1973 Oct-1974 Mar;5(7-12):3-7. Behav Neuropsychiatry. 1973. PMID: 4154740 No abstract available.
• [Effect of prolonged-action neuroleptics on rehospitalization of psychotic patients in a regional practice].

  Richou H. Richou H. Ann Med Psychol (Paris). 1975 Jul;2(2):399-402. Ann Med Psychol (Paris). 1975. PMID: 9894 French. No abstract available.
• [Clinical classification of neuroleptics. Critical study and current prospects].

  Kapsambelis V, Gekiere C, Ginestet D. Kapsambelis V, et al. Encephale. 1990 Mar-Apr;16(2):63-70. Encephale. 1990. PMID: 1972056 Review. French.
• [Differential indication for the use of neuroleptics].

  Vinar O. Vinar O. Act Nerv Super (Praha). 1970 Jan 12;12(1):1-11. Act Nerv Super (Praha). 1970. PMID: 4907389 Review. Czech. No abstract available.